← Back
Data updated: Jun 28, 2026
AGEPHA PHARMA FZ
Pharma Pharmaceuticals
AGEPHA PHARMA FZ is a pharmaceutical company with 1 FDA-approved products.
2023
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
AGEPHA PHARMA FZ's Key Drugs
AGEPHA PHARMA FZ's core commercial portfolio centers on LODOCO — its most strategically important drugs approved in the last 15 years.
AGEPHA PHARMA FZ's Recent FDA Approvals
New NDA/BLA approvals for AGEPHA PHARMA FZ over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
AGEPHA PHARMA FZ's Therapeutic Areas
Disease areas where AGEPHA PHARMA FZ has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
AGEPHA PHARMA FZ Pipeline Snapshot
Active clinical trials for AGEPHA PHARMA FZ across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • LODOCO leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-06-16
- Latest
- 2023-06-16
- Applications
- 1